NCT02601157View on ClinicalTrials.gov

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

2,173

Participants

Timeline

Start Date

January 18, 2016

Primary Completion Date

August 14, 2021

Study Completion Date

August 14, 2022

Conditions
Stable AnginaUnstable AnginaNon-ST Segment Elevation Myocardial Infarction
Interventions
DRUG

3-months DAPT

Contrast to the conventional 1-year DAPT, patients in this group will be followed with 3-months DAPT schedule after the stenting

DRUG

1-year DAPT

Patients in this group will be followed with the conventional 1-year DAPT schedule after the stenting

Trial Locations (12)

Unknown

Busan Paik Hospital, Busan

Kosin University Gospel Hospital, Busan

SoonChunHyang University Cheonan Hospital, Cheonan

Chonnam National University Hospital, Gwangju

Gwangju Christian Hospital, Gwangju

Ewha Womans University Medical Center Mokdong Hospital, Seoul

Hallym University Kangdong Sacred Heart Hospital, Seoul

Kangnam Sacred Heart Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyung Hee University Hospital at Gangdong, Seoul

Seoul National University Hospital, Seoul

Ajou University Hospital, Suwon

All Listed Sponsors
collaborator

B. Braun Korea Co., Ltd.

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT02601157 - Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial | Biotech Hunter | Biotech Hunter